secwatch / observer
8-K filed April 21, 2022, 7:59 PM ET ticker GMED CIK 0001237831
leadership confidence high sentiment neutral materiality 0.70

Globus Medical names Dan Scavilla as CEO replacing Demski; prelim Q1 sales $230.5M +1.4% YoY

GLOBUS MEDICAL INC

item 2.02item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David M. Demski

President and Chief Executive Officer
GMED · GLOBUS MEDICAL INC
Effective
2022-04-21
Successor
Daniel T. Scavilla
Filed
April 21, 2022, 7:59 PM ET
On April 20, 2022, Mr. Demski also notified the Board of his resignation as President and Chief Executive Officer of the Company, effective April 21, 2022.
Appointed

Daniel T. Scavilla

President and Chief Executive Officer
GMED · GLOBUS MEDICAL INC
Effective
2022-04-21
Successor
David M. Demski
Filed
April 21, 2022, 7:59 PM ET
On April 21, 2022, the Board of Directors of the Company approved the appointment of Daniel T. Scavilla as President and Chief Executive Officer, effective April 21, 2022.
Appointed

Daniel T. Scavilla

Director
GMED · GLOBUS MEDICAL INC
Effective
2022-04-21
Successor
David M. Demski
Filed
April 21, 2022, 7:59 PM ET
On April 21, 2022, the Board appointed Mr. Scavilla to serve as a member of the Board and as a member of the Nominating and Corporate Governance Committee with a term expiring at the Company’s annual meeting in 2023 to fill the vacancy created by the resignation of Mr. Demski.
Departed

David M. Demski

Director
GMED · GLOBUS MEDICAL INC
Effective
2022-04-20
Successor
Daniel T. Scavilla
Filed
April 21, 2022, 7:59 PM ET
On April 20, 2022, David M. Demski notified the Chairman of the Board of Directors (the “Board”) of the Company of his resignation from the Board effective April 20, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David M. Demski resigned as President and Chief Executive Officer at GLOBUS MEDICAL INC.

Action
resigned
Role
President and Chief Executive Officer
Exact text from the filing
On April 20, 2022, Mr. Demski also notified the Board of his resignation as President and Chief Executive Officer of the Company, effective April 21, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel T. Scavilla was appointed as President and Chief Executive Officer at GLOBUS MEDICAL INC.

Action
appointed
Role
President and Chief Executive Officer
Exact text from the filing
On April 21, 2022, the Board of Directors of the Company approved the appointment of Daniel T. Scavilla as President and Chief Executive Officer, effective April 21, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel T. Scavilla was appointed as Director at GLOBUS MEDICAL INC.

Action
appointed
Role
Director
Exact text from the filing
On April 21, 2022, the Board appointed Mr. Scavilla to serve as a member of the Board and as a member of the Nominating and Corporate Governance Committee with a term expiring at the Company’s annual meeting in 2023 to fill the vacancy created by the resignation of Mr. Demski.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

David M. Demski resigned as Director at GLOBUS MEDICAL INC.

Action
resigned
Role
Director
Exact text from the filing
On April 20, 2022, David M. Demski notified the Chairman of the Board of Directors (the “Board”) of the Company of his resignation from the Board effective April 20, 2022.
View on SEC.gov

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR
accession 0001562762-22-000187
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.